National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 22502 [2019-10235]

Download as PDF 22502 Federal Register / Vol. 84, No. 96 / Friday, May 17, 2019 / Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued Type of respondent Cohort 2—Youth Aged 11 to 18. Totals ....................... 1 There Cohort 2—Youth Baseline Questionnaire. Cohort 2—Youth 1st, 2nd, 3rd Followup Questionnaire. ......................................... Number of responses per respondent Total annual responses Average burden per response Total hours 2,667 1 2,667 0.75 (45 minutes) ... 2,000 6,270 1 6,270 0.75 (45 minutes) .. 4,703 ........................ ........................ ........................ ................................ 16,525 are no capital costs or operating and maintenance costs associated with this collection of information. To accommodate the additional data collection for media tracking, FDA requests approval to increase the number of burden hours under the existing control number. The previous number of approved screener responses for media tracking was 60,000 and the associated burden was 1,800 hours. The previous burden for the media tracking questionnaires was 6,000 and the associated burden was 3,000 hours. We are requesting an additional 20,000 screener responses and 2,000 questionnaire completions, which adds 600 burden hours and 1,000 burden hours respectively. Deducting the responses and burden for the completed evaluation components associated with Cohort 1 (general population screening (13,413 responses, 2,281 hours), parent interviews (3,342 responses, 569 hours), youth questionnaires (8,954 responses, 6,144 hours)) and for the rural smokeless evaluation (2,610 responses, 1,794 hours) results in a decrease of 6,319 annual responses and 9,187 hours. Dated: May 14, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019–10320 Filed 5–16–19; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Amended Notice of Meeting jbell on DSK3GLQ082PROD with NOTICES Number of respondents Activity Notice is hereby given of a change in the meeting of the National Cancer Institute Council of Research Advocates, May 20, 2019, 9:30 a.m. to 4:00 p.m., National Institutes of Health, Building 40, Room 1201/1203, 40 Convent Drive, Bethesda, MD 20892 which was published in the Federal Register on April 11, 2019, 84 FR 14662. This meeting notice is amended to change the meeting start time from 9:00 a.m. to 9:30 a.m. on May 20, 2019 at the National Institutes of Health, Building VerDate Sep<11>2014 20:15 May 16, 2019 Jkt 247001 40, Room 1201/1203, 40 Convent Drive, Bethesda, MD 20892. This meeting is open to the public. Dated: May 13, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–10217 Filed 5–16–19; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health, Two Democracy Boulevard, Suite 920, 6707 Democracy Blvd., Bethesda, MD 20892, 301–451–4794, dennis.hlasta@nih.gov. Dated: May 13, 2019. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–10235 Filed 5–16–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council on Alcohol Abuse and Alcoholism. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Resources for Technology Dissemination (U24) Review Meeting (2019/08). Date: June 27, 2019. Time: 9:00 a.m. to 7:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging, and Bioengineering, Name of Committee: National Advisory Council on Alcohol Abuse and Alcoholism. Date: June 6, 2019. Time: 1:30 p.m. to 2:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 1206, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Abraham P. Bautista, Ph.D., Executive Secretary, National Advisory Council, Director, Office of Extramural Activities, National Institute On Alcohol Abuse And Alcoholism, 6700 B PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\17MYN1.SGM 17MYN1

Agencies

[Federal Register Volume 84, Number 96 (Friday, May 17, 2019)]
[Notices]
[Page 22502]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10235]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Institute 
of Biomedical Imaging and Bioengineering Special Emphasis Panel.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; Resources for Technology 
Dissemination (U24) Review Meeting (2019/08).
    Date: June 27, 2019.
    Time: 9:00 a.m. to 7:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, Suite 
920, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer, 
National Institute of Biomedical Imaging, and Bioengineering, 
National Institutes of Health, Two Democracy Boulevard, Suite 920, 
6707 Democracy Blvd., Bethesda, MD 20892, 301-451-4794, 
[email protected].

    Dated: May 13, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-10235 Filed 5-16-19; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.